FDAnews
www.fdanews.com/articles/145914-stryker-first-quarter-growth-spurred-by-strong-neurotech-spine-sales

Stryker First-Quarter Growth Spurred By Strong Neurotech, Spine Sales

April 26, 2012
Stryker’s global revenues grew 7.2 percent to $2.2 billion in the 2012 first quarter, bolstered by a 12.4 percent jump in sales of neurotechnology and spine devices. The company attributed the sector’s positive performance in part to the acquisitions of Orthovita and Boston Scientific’s neurovascular division, both announced in the first half of 2011.
Devices & Diagnostics Letter